Ambu A/S (OTCMKTS:AMBBY) Stock Price Down 5.1% – Time to Sell?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares dropped 5.1% on Friday . The stock traded as low as $15.04 and last traded at $15.04. Approximately 633 shares changed hands during trading, an increase of 266% from the average daily volume of 173 shares. The stock had previously closed at $15.85.

Wall Street Analyst Weigh In

Separately, UBS Group upgraded shares of Ambu A/S to a “strong-buy” rating in a research note on Tuesday, May 13th. One analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Strong Buy”.

Ambu A/S Stock Down 5.1%

The firm’s 50 day simple moving average is $15.12 and its 200 day simple moving average is $16.25. The company has a market cap of $3.53 billion, a price-to-earnings ratio of 79.16 and a beta of 0.89. The company has a quick ratio of 1.67, a current ratio of 2.88 and a debt-to-equity ratio of 0.08.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings data on Friday, August 22nd. The company reported $0.07 earnings per share (EPS) for the quarter. The business had revenue of $229.16 million during the quarter. Ambu A/S had a net margin of 5.93% and a return on equity of 6.24%.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.